Her primary areas of investigation include Osteoporosis, Internal medicine, Physical therapy, Surgery and Rheumatology. Her Osteoporosis research incorporates elements of Quality of life, Pediatrics and Risk factor. Her Physical therapy research is multidisciplinary, relying on both Epidemiology, Cohort study, Orthopedic surgery, Randomized controlled trial and Meta-analysis.
Her research integrates issues of Intensive care medicine, Vitamin B12 and Fracture risk, FRAX in her study of Surgery. Her study looks at the relationship between Rheumatology and topics such as Raloxifene, which overlap with Zoledronic acid and Postmenopausal osteoporosis. Her work in Bone density covers topics such as Femoral neck which are related to areas like Alternative medicine.
Alexandra Papaioannou mostly deals with Osteoporosis, Physical therapy, Internal medicine, Surgery and Long-term care. Alexandra Papaioannou has included themes like Orthopedic surgery and Cohort in her Osteoporosis study. Her work focuses on many connections between Physical therapy and other disciplines, such as Randomized controlled trial, that overlap with her field of interest in Meta-analysis.
The study incorporates disciplines such as Diabetes mellitus and Endocrinology in addition to Internal medicine. Her Long-term care research incorporates themes from Intervention and Gerontology. Her Rheumatology study combines topics in areas such as Epidemiology and Sports medicine.
The scientist’s investigation covers issues in Osteoporosis, Physical therapy, Long-term care, Internal medicine and Randomized controlled trial. Alexandra Papaioannou has researched Osteoporosis in several fields, including Body mass index, Orthopedic surgery and Confidence interval. Her Physical therapy study incorporates themes from Psychological intervention, Quality of life and Geriatrics.
Her research investigates the link between Long-term care and topics such as Family medicine that cross with problems in Response rate. Her Internal medicine study frequently involves adjacent topics like Sclerostin. Her research in Randomized controlled trial intersects with topics in Meta-analysis, Intervention, Gerontology and Quality of life.
Alexandra Papaioannou focuses on Physical therapy, Osteoporosis, Randomized controlled trial, Quality of life and Internal medicine. She has researched Physical therapy in several fields, including Psychological intervention, Chronic disease, Sex factors, Geriatrics and Algorithm. Her study in Osteoporosis is interdisciplinary in nature, drawing from both Incidence, Orthopedic surgery, Adverse effect, Radiology and Lumbar spine.
Her Randomized controlled trial research is multidisciplinary, incorporating perspectives in Gerontology, Quality of life, Intervention, Meta-analysis and Dementia. Her Quality of life research is multidisciplinary, incorporating elements of Granisetron, Hip fracture, Pharmacodynamics and Confidence interval. Alexandra Papaioannou focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Diabetes mellitus and, in certain cases, Surgery, Cardiology, Quantitative computed tomography and Muscle atrophy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
Alexandra Papaioannou;Suzanne Morin;Angela M. Cheung;Stephanie Atkinson.
Canadian Medical Association Journal (2010)
Meta-Analyses of Therapies for Postmenopausal Osteoporosis
Ann Cranney;Peter Tugwell;George Wells;Andrew Willan.
Economic implications of hip fracture: health service use, institutional care and cost in Canada.
M. E. Wiktorowicz;R. Goeree;A. Papaioannou;Jonathan D. Adachi.
Osteoporosis International (2001)
Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
J. Brent Richards;Alexandra Papaioannou;Jonathan D. Adachi;Lawrence Joseph.
JAMA Internal Medicine (2007)
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study
George Ioannidis;Alexandra Papaioannou;Wilma M Hopman;Noori Akhtar-Danesh.
Canadian Medical Association Journal (2009)
A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.
Jean-Jacques Body;Gregory A. Gaich;Wim H. Scheele;Pandurang M. Kulkarni.
The Journal of Clinical Endocrinology and Metabolism (2002)
Trends in hip fracture rates in Canada.
William D. Leslie;Siobhan O’Donnell;Sonia Jean;Claudia Lagacé.
Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon
L. Giangregorio;A. Papaioannou;A. Cranney;N. Zytaruk.
Seminars in Arthritis and Rheumatism (2006)
III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis
Ann Cranney;Peter Tugwell;Jonathan Adachi;Bruce Weaver.
Endocrine Reviews (2002)
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada.
J. D. Adachi;G. Ioannidis;C. Berger;L. Joseph.
Osteoporosis International (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: